You’ve been hearing about growth hormone peptides. Maybe your trainer mentioned them for recovery. Maybe you read that they improve deep sleep and body composition. Maybe you’re in your late 30s or 40s and noticing that recovery takes longer, sleep is lighter, and the gym results that used to come easily now require twice the effort. So you started researching CJC-1295 and Ipamorelin — and immediately hit a wall of contradictory information. Biohacking forums say it’s a game-changer. Skeptics say it’s snake oil. Clinics say it’s the future of anti-aging. Nobody seems to be giving you a straight answer about what the research actually supports. That’s what this page is for.
CJC-1295 / Ipamorelin
Growth Hormone Secretagogue Combination
Also known as: Modified GRF 1-29 (CJC-1295), CJC/Ipa
Evidence Summary
- Strongest evidence for:
- GH and IGF-1 elevation (documented in human studies). Synergistic effect when combined — 1999 research showed simultaneous stimulation produces GH output greater than sum of individual responses.
- Promising but early:
- Sleep quality improvement, body composition changes
- Mostly anecdotal:
- Anti-aging effects, cognitive benefits
- Key limitation:
- While individual compounds have human data, most outcome claims rely on mechanistic reasoning and clinical observation rather than large RCTs.
What It Is
CJC-1295 and Ipamorelin are growth hormone secretagogues — they stimulate your pituitary gland to produce more growth hormone naturally. CJC-1295 works through GHRH receptors. Ipamorelin works through ghrelin receptors. They target different pathways, which is why the combination is the most commonly prescribed GH peptide protocol. Unlike synthetic HGH (which replaces your natural production), these peptides enhance your body’s own GH output.
What the Research Says
GH Synergy
T2: Emerging EvidenceClinical research demonstrated combined stimulation produces synergistic GH output significantly greater than either compound alone. One of the few peptide combinations with genuine clinical evidence for the pairing itself.
Ipamorelin Selectivity
T2: Emerging EvidenceUnlike older secretagogues (GHRP-2, GHRP-6), Ipamorelin primarily stimulates GH without significantly elevating cortisol, prolactin or other unwanted hormones.
Sleep
T2: Emerging EvidenceGH secretion is linked to deep sleep. Mechanistically supported and widely reported by patients and practitioners.
Body Composition
T3: Early / AnecdotalMechanistically supported through GH/IGF-1 pathways but limited RCT-level evidence for this combination specifically.
It’s worth noting: without controlled human trials, we can’t rule out that practitioner-reported benefits are placebo, coincidental with other interventions or overstated. The mechanistic rationale is sound, but sound rationale isn’t proof.
Typical Protocol
| Route | Subcutaneous injection |
| Dosage Range | CJC-1295: 100–300 mcg, Ipamorelin: 100–300 mcg |
| Frequency | 1–2x daily, typically before bed |
| Cycle Length | 8–12 weeks on, 4 weeks off |
| Time to Effect | Sleep improvements often within 1–2 weeks, body composition changes 4–8 weeks |
| Note | Your provider determines dosing. With or without DAC — ask your provider why they recommend their approach. |
Protocols vary by individual. Always follow your prescribing provider's instructions.
Risks & Side Effects
- Injection site reactions.
- Water retention (usually mild and temporary).
- Blood sugar effects — GH compounds can affect glucose metabolism, monitor if pre-diabetic.
- Tingling or numbness in extremities.
- Headache.
- Potential interaction with diabetes medications.
Who Should Not Consider CJC-1295 / Ipamorelin
If you have an active cancer or tumor history: GH and IGF-1 elevation are growth signals. While CJC-1295/Ipamorelin produces a more physiological GH pulse than synthetic HGH, the underlying concern is the same: stimulating growth pathways in someone with an active or recent malignancy is not a risk most oncologists would accept. This conversation belongs with your oncologist, not your peptide provider.
If you are diabetic or have blood sugar dysregulation: GH directly affects insulin sensitivity and glucose metabolism. If you are diabetic, pre-diabetic, or have a history of metabolic syndrome, CJC-1295/Ipamorelin can shift your glycemic control in ways that require active monitoring and possible medication adjustment. Your endocrinologist must be in the loop — not just informed after the fact.
If you are pregnant or breastfeeding: No safety data exists in pregnant or lactating populations. Absolute contraindication.
If you have an active pituitary disorder: These compounds work by stimulating your own pituitary to release GH. If your pituitary axis is already dysregulated — acromegaly, prolactinoma, hypopituitarism, or post-surgical pituitary changes — adding a secretagogue is not appropriate without endocrinology supervision.
If you are unwilling to get baseline labs: Baseline IGF-1 and fasting glucose are not optional with this protocol. They’re how you and your provider know whether the compound is doing what it’s supposed to and whether it’s causing harm you can’t feel. If a provider is willing to prescribe this without baseline labs, that is a red flag about the provider, not a feature.
Legal & Access Status
Both CJC-1295 and Ipamorelin are Category 2 but were referred to PCAC in September 2024 — they are the furthest along in the formal reclassification process. Expected to return to Category 1. Not yet legally compoundable under standard rules, though some providers operate in a regulatory gray zone for PCAC-referred compounds.
Before You Start: Get Baseline Labs
We recommend baseline lab work before starting any peptide protocol so you and your provider can track changes. Key markers include IGF-1, fasting glucose, CBC, CMP and a thyroid panel.
Ask your provider about ordering these labs, or search for direct-to-consumer lab testing services in your area.
Lab recommendations are the same regardless of which service you use. See how we make money.
What You'll Need
If your provider prescribes an injectable protocol, you'll need basic supplies.
- Bacteriostatic Water (30ml)Link coming soon
- Insulin Syringes 29 gauge (100ct)Link coming soon
- Alcohol Prep Pads (200ct)Link coming soon
- Sharps ContainerLink coming soon
Supply links are affiliate links. We may earn a commission at no cost to you. We only link to commodity supplies, never to peptide products. See how we make money.
Questions for Your Provider
- 1What are my baseline GH and IGF-1 levels?
- 2CJC-1295 with or without DAC — and why?
- 3What monitoring schedule do you recommend?
- 4How will we track whether this is working — labs, sleep data, body composition?
- 5Are there blood sugar concerns given my health history?
- 6How does this interact with any other medications or supplements I’m taking?
Find a Provider
We’re finalizing our vetted provider list. Subscribe to be notified when provider recommendations go live.
When provider links go live, we’ll disclose all affiliate relationships here. See how we make money.
Stay ahead of the FDA.
Regulatory updates as developments happen. New compound profiles weekly. No spam. No sales pitches.